Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 24157 | BTA-EG4 hydrate | 921193-28-4 | 98% Min. |  |
| BTA-EG4 is a catalase-amyloid interaction inhibitor, which can significantly enhance | ||||
| 24117 | Bexicaserin | 2035818-24-5 | 98% Min. |  |
| Bexicaserin is a serotonin 5-HT2C receptor agonist. | ||||
| 24086 | BIIB-129 | 2770961-85-6 | 98% Min. |  |
| 24059 | 4-Bromoindole-3-carboxaldehyde | 98600-34-1 | 98% Min. |  |
| 24034 | Braco-19 trihydrochloride | 351351-75-2 | 98% Min. |  |
| Braco-19 is a potenttelomerase/telomereinhibitor, preventing the capping and catalyti | ||||
| 24025 | BIIB-129 | 2770960-52-4 | ≧98.0% |  |
| BIIB129 is a covalent, selective, small molecule inhibitor of Bruton's tyrosine k | ||||
| 20668 | BLU-451 | 2769954-39-2 | 98% Min. |  |
| BLU-451, also known as LNG-451, orally bioavailable, central nervous system (CNS) pen | ||||
| 24001 | Bomedemstat | 1990504-34-1 | ≧98.0% |  |
| Bomedemstat is anorally available, irreversible inhibitor of lysine-specific demethyl | ||||
| 20620 | Brexpiprazole | 913611-97-9 | 98% Min. |  |
| Brexpiprazole, also known as OPC-34712, is a novel D2 dopamine partial agonist called | ||||
| 20619 | Berotralstat HCl | 1809010-52-3 | 98% Min. |  |
| Berotralstat HCl is a novel selective inhibitor of plasma kallikrein, blocking the en | ||||
| 20606 | Belzutifan | 1672668-24-4 | 98% Min. |  |
| Belzutifan, also known as PT2977 and MK-6482, is HIF-2alpha inhibitor. PT2977 binds t | ||||
| 20601 | BI-1467335 HCl | 1478364-68-9 | 98% Min. |  |
| BI-1467335, also known as PXS-4728A, is a SSAO/VAP inhibitor potentially for the trea | ||||
| 20599 | Bozitinib | 1440964-89-5 | 98% Min. |  |
| Bozitinib is a highly selective c-MET kinase inhibitor with blood-brain barrier perme | ||||
| 20597 | BMS-986176 | 1815613-42-3 | 98% Min. |  |
| BMS-986176, also known as LX9211, is a highly selective, CNS penetrant, potent AAK1 i | ||||
| 20570 | BBT | 445000-45-3 | 98% Min. |  |
| BBT is an enhancer of impaired glucose-stimulated insulin secretion (GSIS). | ||||
| 20554 | BML-278 | 120533-76-8 | 98% Min. |  |
| BML-278 is an activator of sirtuin 1 (SIRT1) that has an EC150 value (effective conce | ||||
| 20550 | BSJ-04-122 | 2513289-74-0 | 98% Min. |  |
| 20533 | brigimadlin | 2095116-40-6 | 98% Min. |  |
| Brigimadlin is an E3 ubiquitin-protein ligase Mdm2 inhibitor with potential as an ant | ||||
| 20519 | BMS-986120 | 1478712-37-6 | 98% Min. |  |
| BMS-986120 is a potent and selective oral antagonist of protease-activated receptor-4 | ||||
| 20518 | BMS-986141 | 1478711-48-6 | 98% Min. |  |
| BMS-986141 is an Orally-Active Small-Molecule Antagonist of the Platelet Protease-Act | ||||
| 20512 | BDTX-1535 | 2607829-38-7 | ≧98.0% |  |
| BDTX-1535 is a brain-penetrant and potent MasterKey inhibitor of oncogenic mutations | ||||
| 232252 | Brepocitinib Tosylate | 2140301-96-6 | ≧98.0% |  |
| Brepocitinib ( PF-06700841 ) is an orally available, selective inhibitor of non-recep | ||||
| 20496 | BRD4 degrader AT1 | 2098836-45-2 | 98% Min. |  |
| BRD4 degrader AT1 is an analogue of MZ1. It shows improved selectivity for BRD4 degra | ||||
| 20492 | BJJF078 | 2531244-56-9 | 98% Min. |  |
| BJJF078 is a potent inhibitor of recombinant human and mouse Transglutaminase enzyme | ||||
| 20485 | BRD0639 | 2760881-74-9 | 98% Min. |  |
| BRD0639 is a potent PRMT5 inhibitor. BRD0639 engages the target in cells, disrupts PR | ||||
| 230402 | BI 1015550 ( Nerandomilast ) | 1423719-30-5 | ≧98.0% |  |
| BI 1015550 ( Nerandomilast )is an oral, preferential inhibitor of phosphodiesterase 4 | ||||
| 20469 | BT44 | 924759-42-2 | 98% Min. |  |
| BT44 is a novel RET agonist for the treatment of experimental neuropathies. | ||||
| 232251 | Brepocitinib ( PF-06700841 ) | 1883299-62-4 | ≧98.0% |  |
| Brepocitinib is a potential first-in-class dual, selective inhibitor of TYK2 and JAK1 | ||||
| 20453 | BIIB068 | 1798787-27-5 | 98% Min. |  |
| 20451 | Baxdrostat | 1428652-17-8 | 98% Min. |  |
| Baxdrostat is an aldosterone synthase inhibitor. | ||||